Person

Joseph Michael Fitzgerald

EVP & Group Pres, Cardiology, Boston Scientific

Current S&P 500 boards
0
Current roles
1
Open-market buys
$5K
Open-market sales
$76.9M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Nov 3, 2025BSXSale16,928$99.76$1.7M
Nov 3, 2025BSXSale29,472$99.14$2.9M
Nov 3, 2025BSXSale3,600$100.75$363K
Oct 1, 2025BSXSale8,245$98.91$816K
Oct 1, 2025BSXSale41,755$98.38$4.1M
Sep 2, 2025BSXSale21,830$104.89$2.3M
Sep 2, 2025BSXSale28,170$105.85$3.0M
Aug 1, 2025BSXSale50,000$104.63$5.2M
Jul 1, 2025BSXSale50,000$106.97$5.3M
Jun 4, 2025BSXSale56,372$102.88$5.8M
Dec 10, 2024BSXSale20$89.97$2K
Dec 3, 2024BSXBuy50$90.29$5K
Oct 7, 2024BSXSale132,527$85.00$11.3M
Aug 28, 2024BSXSale14,132$80.00$1.1M
Jan 12, 2024BSXSale11,660$60.00$700K
Dec 29, 2023BSXSale81,940$57.50$4.7M
Sep 20, 2023BSXSale15,867$55.00$873K
May 16, 2023BSXSale63,339$53.60$3.4M
Dec 13, 2022BSXSale79,264$47.78$3.8M
Jul 27, 2021BSXSale105,490$45.00$4.7M
Sep 11, 2020BSXSale77,640$40.76$3.2M
Dec 13, 2019BSXSale107,692$45.00$4.8M
Jul 1, 2019BSXSale20,673$43.41$897K
Jun 28, 2019BSXSale1,906$43.00$82K
Feb 12, 2019BSXSale44,236$40.00$1.8M
Feb 7, 2018BSXSale85,227$26.48$2.3M
May 3, 2016BSXSale79,960$21.81$1.7M

SEC reporting-owner ID (CIK) 1484186 · all filings on EDGAR

Joseph Michael Fitzgerald (BSX) | USBoard